Sfoglia per Autore
RIFN BETA-1A AND SICAM-1 EFFECTS ON CD4+CD45RO+ PBTLS EXPRESSING LFA-1 IN RR MS: IN VIVO AND IN VITRO STUDY
2000-01-01 Avolio, C; Ruggieri, Maddalena; Cafforio, P; Giuliani, F; Silvestris, Francesco; Livrea, P. AND TROJANO M.
MMP-9 and 2 activities and TIMPs in MS: differences between early and chronic disease
2001-01-01 Avolio, C; Ruggieri, Maddalena; Giuliani, F; Livrea, P. AND TROJANO M.
Serum MMPs and TIMPs in Multiple Sclerosis: differences between early and chronic disease
2001-01-01 Avolio, C; Ruggieri, Maddalena; Giuliani, F; Livrea, P. AND TROJANO M.
MMPS AND TIMPS ARE DIFFERENTLY RELATED TO MS COURSES AND PHASES OF THE DISEASE
2001-01-01 Avolio, C; Ruggieri, Maddalena; Giuliani, F; Liuzzi, Grazia Maria; Riccio, P; Livrea, P. AND TROJANO M.
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy
2001-01-01 Troiano, Maria; Paolicelli, Damiano; Liguori, M; Zimatore, Gb; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P.
SERUM AND CSF CHANGES OF MATRIX METALLOPROTEINASES (MMPS) AND THEIR TISSUE INHIBITORS (TIMPS) DURING DISEASE COURSE AND INTERFERON BETA TREATMENT IN MULTIPLE SCLEROSIS (MS)
2001-01-01 Troiano, Maria; Avolio, C; Liuzzi, Grazia Maria; Paolicelli, Damiano; Giuliani, F; Paolicelli, D; Ruggieri, Maddalena; Livrea, P.
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNb-1a
2001-01-01 Avolio, C; Ruggieri, Maddalena; Cafforio, Paola; Giuliani, F; Silvestris, Francesco; Dammacco, F; Livrea, Paolo; Troiano, Maria
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy
2002-01-01 Troiano, Maria; Paolicelli, Damiano; Liguori, M; Zimatore, Gb; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P.
Matrix metalloproteinases and disease corse in Multiple Sclerosis
2003-01-01 Avolio, C; Ruggieri, Maddalena; Modesto, M; Tortorella, P; Specchio, Lm; Livrea, P; Troiano, Maria
Correlations between neutralizing antibodies production and clinical outcomes: analysis in a population-based surveillance italian study of interferon beta treatment in multiple sclerosis patients
2003-01-01 Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Gb, Zimatore; Livrea, P; Troiano, Maria
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA
2003-01-01 Avolio, C; Giuliani, F; Liuzzi, Grazia Maria; Ruggieri, Maddalena; Paolicelli, Damiano; Livrea, P. AND TROJANO M.
lesions in Multiple Sclerosis (MS)
2003-01-01 Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli,
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
2003-01-01 Avolio, C; Ruggieri, Maddalena; Giuliani, F; Liuzzi, Grazia Maria; Leante, R; Riccio, P; Livrea, Paolo; Troiano, Maria
MMPs and TIMPs involvement at the blood-brain barrier level in MS: comparison between patients enhancing with different doses of gadolinium during rIFNb-1a treatment
2003-01-01 Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli, C; Stecchi, S; Livrea, P; Troiano, Maria
Neutralizing antibodies during treatment of relapsing Multiple Sclerosis patients with three interferon beta: correlation with clinical outcomes
2003-01-01 Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P; Troiano, Maria
A population-based surveillance Italian study of Interferon beta treatment in Multiple Sclerosis patients: relationships between neutralizing antibodies production and clinical outcomes
2003-01-01 Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P; Troiano, Maria
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta
2003-01-01 Avolio, C.; Giuliani, F.; Liuzzi, Grazia Maria; Ruggieri, M.; Paolicelli, Damiano; Riccio, P.; Livrea, Paolo; Troiano, Maria
Standard (SD) and triple dose (TD) gadolinium (Gd) enhancing lesions are associated with a similar degree of MMP-9 and TIMP-1 involvement at the blood-brain barrier (BBB) level in Multiple Sclerosis (MS)
2003-01-01 Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli, C; Stecchi, S; Livrea, P; Troiano, Maria
Italian studies on early-onset multiple sclerosis: the present and the future
2004-01-01 Ghezzi, A; Ruggieri, Maddalena; Troiano, Maria; Filippi, M; ITEMS STUDY, Group
Beta Amyloid 1-40 peptide selectively downregulates MMP-9 production in differentiated SH-SY5Y neuronal cell line
2004-01-01 Ruggieri, Maddalena; Roselli, F; Pica, C; Lia, A; Avolio, C; Troiano, Maria; Livrea, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
RIFN BETA-1A AND SICAM-1 EFFECTS ON CD4+CD45RO+ PBTLS EXPRESSING LFA-1 IN RR MS: IN VIVO AND IN VITRO STUDY | 1-gen-2000 | Avolio, C; Ruggieri, Maddalena; Cafforio, P; Giuliani, F; Silvestris, Francesco; Livrea, P. AND TROJANO M. | |
MMP-9 and 2 activities and TIMPs in MS: differences between early and chronic disease | 1-gen-2001 | Avolio, C; Ruggieri, Maddalena; Giuliani, F; Livrea, P. AND TROJANO M. | |
Serum MMPs and TIMPs in Multiple Sclerosis: differences between early and chronic disease | 1-gen-2001 | Avolio, C; Ruggieri, Maddalena; Giuliani, F; Livrea, P. AND TROJANO M. | |
MMPS AND TIMPS ARE DIFFERENTLY RELATED TO MS COURSES AND PHASES OF THE DISEASE | 1-gen-2001 | Avolio, C; Ruggieri, Maddalena; Giuliani, F; Liuzzi, Grazia Maria; Riccio, P; Livrea, P. AND TROJANO M. | |
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy | 1-gen-2001 | Troiano, Maria; Paolicelli, Damiano; Liguori, M; Zimatore, Gb; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P. | |
SERUM AND CSF CHANGES OF MATRIX METALLOPROTEINASES (MMPS) AND THEIR TISSUE INHIBITORS (TIMPS) DURING DISEASE COURSE AND INTERFERON BETA TREATMENT IN MULTIPLE SCLEROSIS (MS) | 1-gen-2001 | Troiano, Maria; Avolio, C; Liuzzi, Grazia Maria; Paolicelli, Damiano; Giuliani, F; Paolicelli, D; Ruggieri, Maddalena; Livrea, P. | |
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNb-1a | 1-gen-2001 | Avolio, C; Ruggieri, Maddalena; Cafforio, Paola; Giuliani, F; Silvestris, Francesco; Dammacco, F; Livrea, Paolo; Troiano, Maria | |
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy | 1-gen-2002 | Troiano, Maria; Paolicelli, Damiano; Liguori, M; Zimatore, Gb; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P. | |
Matrix metalloproteinases and disease corse in Multiple Sclerosis | 1-gen-2003 | Avolio, C; Ruggieri, Maddalena; Modesto, M; Tortorella, P; Specchio, Lm; Livrea, P; Troiano, Maria | |
Correlations between neutralizing antibodies production and clinical outcomes: analysis in a population-based surveillance italian study of interferon beta treatment in multiple sclerosis patients | 1-gen-2003 | Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Gb, Zimatore; Livrea, P; Troiano, Maria | |
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA | 1-gen-2003 | Avolio, C; Giuliani, F; Liuzzi, Grazia Maria; Ruggieri, Maddalena; Paolicelli, Damiano; Livrea, P. AND TROJANO M. | |
lesions in Multiple Sclerosis (MS) | 1-gen-2003 | Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli, | |
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes | 1-gen-2003 | Avolio, C; Ruggieri, Maddalena; Giuliani, F; Liuzzi, Grazia Maria; Leante, R; Riccio, P; Livrea, Paolo; Troiano, Maria | |
MMPs and TIMPs involvement at the blood-brain barrier level in MS: comparison between patients enhancing with different doses of gadolinium during rIFNb-1a treatment | 1-gen-2003 | Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli, C; Stecchi, S; Livrea, P; Troiano, Maria | |
Neutralizing antibodies during treatment of relapsing Multiple Sclerosis patients with three interferon beta: correlation with clinical outcomes | 1-gen-2003 | Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P; Troiano, Maria | |
A population-based surveillance Italian study of Interferon beta treatment in Multiple Sclerosis patients: relationships between neutralizing antibodies production and clinical outcomes | 1-gen-2003 | Paolicelli, Damiano; Avolio, C; Lavolpe, V; Ruggieri, Maddalena; Livrea, P; Troiano, Maria | |
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta | 1-gen-2003 | Avolio, C.; Giuliani, F.; Liuzzi, Grazia Maria; Ruggieri, M.; Paolicelli, Damiano; Riccio, P.; Livrea, Paolo; Troiano, Maria | |
Standard (SD) and triple dose (TD) gadolinium (Gd) enhancing lesions are associated with a similar degree of MMP-9 and TIMP-1 involvement at the blood-brain barrier (BBB) level in Multiple Sclerosis (MS) | 1-gen-2003 | Avolio, C; Filippi, M; Tortorella, C; Rocca, M; Ruggieri, Maddalena; Tommasini, V; Pozzilli, C; Stecchi, S; Livrea, P; Troiano, Maria | |
Italian studies on early-onset multiple sclerosis: the present and the future | 1-gen-2004 | Ghezzi, A; Ruggieri, Maddalena; Troiano, Maria; Filippi, M; ITEMS STUDY, Group | |
Beta Amyloid 1-40 peptide selectively downregulates MMP-9 production in differentiated SH-SY5Y neuronal cell line | 1-gen-2004 | Ruggieri, Maddalena; Roselli, F; Pica, C; Lia, A; Avolio, C; Troiano, Maria; Livrea, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile